BALTIMORE (WJZ) — A Baltimore-based company is gearing up to mass-produce a COVID-19 vaccine once it’s approved.
Inside Emergent BioSolutions, employees are ramping up their efforts, anticipating the approval of a COVID-19 vaccine.READ MORE: Baltimore County Police Shoot and Kill Suspect In Woodlawn; 2 Other Victims Found Dead
Sean Kirk is the Executive Vice President of Manufacturing. He said the facility will make the bulk of the vaccine and ship it out to be filled into the vials that many people are used to seeing in a clinic.
- TIMELINE: Coronavirus In Maryland, Tracking The Spread
- Latest coronavirus stories from WJZ
- Latest CDC Guidelines
The company is the primary North American manufacturer for the AstraZeneca and Johnson & Johnson vaccine candidates.READ MORE: Police Activity near Kent Island Causing Major Delays At Bay Bridge
Although, if need be, Emergent BioSolutions is able to support other vaccine candidates, too.
“We have a great, talented workforce from the Baltimore-area and we are leveraging that talent in the fight against COVID each and every day,” Kirk said.
Over the next year, Emergent BioSolutions said it will likely produce and ship hundreds of millions of doses of the vaccine.MORE NEWS: COVID-19 In Maryland: Positivity Rate Continues To Fall As More Than 600 Cases Are Reported Saturday